Canaccord Genuity Reiterates a 'Buy' on Immunogen (IMGN); Strong 2012 Catalyst Lineup
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Immunogen Inc. (NASDAQ: IMGN) price target of $17.00.
Analyst, George Farmer, said, "With several 2012 clinical and regulatory catalysts that we expect to support continued stock momentum, we reiterate our rating on IMGN...IMGN reported December-end cash was $168M. We estimate June F2012-end cash of $152M as sufficient into late 2014."
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
Shares of Immunogen Inc. closed at $13.83 yesterday.
Analyst, George Farmer, said, "With several 2012 clinical and regulatory catalysts that we expect to support continued stock momentum, we reiterate our rating on IMGN...IMGN reported December-end cash was $168M. We estimate June F2012-end cash of $152M as sufficient into late 2014."
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
Shares of Immunogen Inc. closed at $13.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
